A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.

Farhat, Fadi S; Temraz, Sally; Kattan, Joseph; Ibrahim, Khaled; Bitar, Nizar; Haddad, Nadine; Jalloul, Rahif; Hatoum, Hassan A; Nsouli, Ghazi; Shamseddine, Ali I

Farhat, Fadi S; Temraz, Sally; Kattan, Joseph; Ibrahim, Khaled; Bitar, Nizar; Haddad, Nadine; Jalloul, Rahif; Hatoum, Hassan A; Nsouli, Ghazi; Shamseddine, Ali I.

Affiliation

Farhat FS; Hammoud Hospital University Medical Center, Saida, Lebanon.

Clin Breast Cancer ; 11(6): 384-9, 2011 Dec.

Article in En | MEDLINE | ID: mdl-21993011

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/drug therapy; Adolescent; Adult; Aged; Breast Neoplasms/metabolism; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Cisplatin/administration & dosage; Cisplatin/adverse effects; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2/metabolism; Sensory Receptor Cells/metabolism; Treatment Outcome; Vinblastine/administration & dosage; Vinblastine/adverse effects; Vinblastine/analogs & derivatives; Vinorelbine; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Lebanon Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google